¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø °£Áúȯ ½ÉÆ÷Áö¾ö : 2023-04-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

¼­¿ï¾Æ»êº´¿ø °£Áúȯ ½ÉÆ÷Áö¾ö : 2023-04-08
±³À°ÀÏÀÚ : 2023-04-08
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ¼Ò°­´ç

±³À°ÁÖÁ¦ : ¼­¿ï¾Æ»êº´¿ø °£Áúȯ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ¹ÚÁø¾Æ
¿¬¶ôó : 02-3010-1334  

À̸ÞÀÏ : pred1054@amc.seoul.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 09:10~09:20 Chronic hepatitis B: what ¾çÁö¿ø(¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â³»°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 09:20~09:30 LDLT for HCC with portal vein tumor thrombus À±¿µÀÎ(¼­¿ï¾Æ»êº´¿ø °£ÀÌ½Ä ¹× °£´ãµµ¿Ü°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 09:30~09:40 Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS ÃÖ¼¼Áø(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 09:40~09:50 The role of interventional radiology in liver diseases from recently published articles at AMC ±è°ÇÇÏ(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 09:50~10:00 Ongoing oncology translational research in HCC ±èÇüµ·(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 10:00~10:10 The predictive value of liver volume on hepatic decompensation and the long-term effects of stereotactic body radiation therapy on hepatic decompensation À̼ö¹Î(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 10:25~10:45 Effective HCC surveillance in the era of precision medicine ÃÖ¿ø¹¬(¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â³»°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 10:45~11:05 Newly developed biomarkers for early detection of HCC (ex. Liquid biopsy) ÀÌÇý¿ø(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±â³»°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 11:05~11:25 Updates of imaging tests for HCC surveillance ¹ÚÈ¿Á¤(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

Åä·Ð 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 11:25~11:35 Q & A, Discussion ()

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 13:00~13:30 HCC biology and precision medicine Jean Charles Nault(INSERM (France))

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 13:30~14:00 Prediction of microvascular invasion of HCC on gadoxetate-enhanced MRI Yoshimitsu Kengo(Fukuoka University (Japan))

Åä·Ð 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 14:00~14:10 Q & A, Discussion ()

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 14:30~14:50 Robotic hepatectomy ±è°ü¿ì(µ¿¾Æ´ëÇб³º´¿ø ¿Ü°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 14:50~15:10 Recent updates of image-guided ablation therapy À̹οì(»ï¼º¼­¿ïº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 15:10~15:30 Transarterial embolotherapy: which modalities would be best for my patients ±Çµ¿ÀÏ(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 15:30~15:50 Systemic treatment: not confined to advanced stage of HCC õÀç°æ(ºÐ´çÂ÷º´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 15:50~16:10 Radiation therapy: an indispensable weapon in various stages of HCC À¯Á¤ÀÏ(»ï¼º¼­¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

Åä·Ð 04-08 µ¿°ü 6Ãþ ¼Ò°­´ç 16:10~16:20 Q & A, Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø °£Áúȯ ½ÉÆ÷Áö¾ö : 2023-04-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ º¸¼ö±³À° (¿ÀÈÄ) : 2023-04-09
´ÙÀ½±Û ´ëÇѼÒÈ­±âÇÐȸ SIDDS 2023 In Conjunction with the Annual Meeting of the KSG (1ÀÏÂ÷) : 2023-04-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
437 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇѳú½Å°æÀçÈ°ÇÐȸ 2018³âµµ ¿öÅ©¼ó : 2018-09-15 0 625 2018-08-15
436 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇѳú½Å°æÀçÈ°ÇÐȸ 2018³âµµ Ã߰迬¼ö°­Á : 2018-09-15 0 352 2018-08-15
435 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15 0 848 2018-08-15
434 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-15 0 890 2018-08-15
433 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-14 0 966 2018-08-15
432 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 3ÀÏÂ÷ : 2018-09-14 0 2,518 2018-08-15
431 °æ³² ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ¿µ³²ÁöºÎ 2018³â 9¿ù Áý´ãȸ : 2018-09-14 0 974 2018-08-15
430 °æ±â ±¹¸³¾Ï¼¾ÅÍ 2018³â 3Â÷ ÀÇ»ý¸í°úÇÐÆ÷·³ : 2018-09-14 0 774 2018-08-15
429 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-14 0 632 2018-08-15
428 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-14 0 1,484 2018-08-15
427 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 2ÀÏÂ÷ : 2018-09-13 0 1,551 2018-08-15
426 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø À̺ñÀÎÈÄ°ú Áý´ãȸ : 2018-09-11 0 515 2018-08-15
425 °æ±â ÇѾç´ëÇб³±¸¸®º´¿ø °©»ó¼± Á¾¾çÀÇ Áø´Ü°ú Ä¡·á: Ãֽŵ¿Çâ : 2018-09-11 0 453 2018-08-15
424 ºÎ»ê Á¦493Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2018-09-10 0 519 2018-08-15
423 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 12ȸ °¡Å縯¼ºÇü½ÉÆ÷Áö¾ö : 2018-09-09 0 809 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷